Financials

News Ideas Discussions Technicals Seasonals

NUMI fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

‪13.86 M‬CAD

—

—

—

1962

—

Michael Tan

About

Numinus Wellness, Inc. engages in the development of psychedelic-centered therapeutic products. It also provides psychedelic, therapy, neurology, wellness, clinical trials, and training services. The company was founded by Payton Nyquvest and Stacey Wallin on June 26, 1962 and is headquartered in Vancouver, Canada.

Ownership

‪‪326.42 M‬‬

Free Float shares

‪‪313.84 M‬‬ (96.15%)

Closely held shares

‪‪12.58 M‬‬ (3.85%)

Free Float shares

‪‪313.84 M‬‬ (96.15%)

Closely held shares

‪‪12.58 M‬‬ (3.85%)

Capital structure

No data available

There's currently no data to show about this capital structure.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

‪‪13.86 M‬‬

Price to earning ratio (P/E)

—

Price to sales ratio (P/S)

—

Market Cap

Net income

Revenue

Price to earning ratio (P/E)

—

Price to sales ratio (P/S)

—

Valuation ratios

Q1 '24

Q2 '24

Q3 '24

Q4 '24

Q1 '25

‪0.00‬

‪0.40‬

‪0.80‬

‪1.20‬

‪1.60‬

P/S

Growth and Profitability

Company’s recent performance and margins

Performance

‪−122%‬

‪−109%‬

‪−96%‬

‪−83%‬

‪−70%‬

Q1 '24

Q2 '24

Q3 '24

‪‪−6.00 M‬‬

‪‪−3.00 M‬‬

‪0.00‬

‪‪3.00 M‬‬

‪‪6.00 M‬‬

Revenue

Net income

Net margin %

Revenue to profit conversion

No data available

There's currently no revenue data to show for the selected period.

Estimates

Revenue and Earnings forecasts and estimates accuracy

Revenue

Q1 '24

Q2 '24

Q3 '24

Q4 '24

Q2 '25

‪0.00‬

‪‪1.70 M‬‬

‪‪3.40 M‬‬

‪‪5.10 M‬‬

‪‪6.80 M‬‬

Actual

Estimate

Earnings

Next:Apr 10, 2025

Q1 '24

Q2 '24

Q3 '24

Q4 '24

Q2 '25

‪−0.02‬

‪−0.01‬

‪−0.01‬

‪−0.01‬

‪0.00‬

Actual

Estimate

Dividends

Dividend yield, history and sustainability

NUMI does not pay dividends

The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company

Debt level and coverage

Q1 '24

Q2 '24

Q3 '24

Q4 '24

Q1 '25

‪‪−8.00 M‬‬

‪‪−4.00 M‬‬

‪0.00‬

‪‪4.00 M‬‬

‪‪8.00 M‬‬

Debt

Free cash flow

Cash & equivalents

Financial position analysis

No data available

There's currently no assets and liabilities data to show.